Breast Cancer Survivorship and Level of Institutional Involvement Utilizing Integrative Oncology

Table 4

Percentage of patients receiving conventional medical treatments in any line of therapy postdiagnosis, circa 2013–2014.

Conventional medical treatment	Low integrative score (n = 35) (%)	Low-mid integrative score (n = 48) (%)	Mid-high integrative score (n = 26) (%)	High integrative score (n = 64) (%)
Chemotherapy (monotherapy)	43	50	42	27
Chemotherapy + immuno-oncology agent	9	17	12	9
Chemotherapy + targeted therapy	0	0	0	2
Immuno-oncology agent (monotherapy)	3	4	4	0
Targeted therapy (monotherapy)	0	2	0	5
Hormone therapy (monotherapy or in combination)	51	67	88	73
Surgery (excluding diagnostic procedures)	91	98	85	94
Radiation	69	56	69	48